CompletedNot Applicable

Cost Utility Analysis of Erythropoietin for Anemia Treatment in Hemodialysis Patients

Thailand152 participantsStarted 2009-11

Plain-language summary

To study the cost utility analysis of Erythropoietin (EPO) for maintaining the different hemoglobin (Hb) target levels in anemic hemodialysis patient in routine clinical practice.

Who can participate

Age range

18 Years – 85 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients use EPO at least 6 months with titration of EPO therapy is permitted Exclusion Criteria: * Patients under 18 years old. * Patients who have blood transfusion for anemic treatment within 6 months before EPO treatment and before the study starts * Patients who change the modality of dialysis * Patients who switch to other anemia treatment method between the study * Patients who cannot answer the questionnaire and are not willing to participate in the study

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

The utility scores of hemodialysis (HD) patients who use EPO to maintain the Hb target level.

Timeframe: 1 year

Cost of HD patients who use EPO to maintain the Hb target level.

Timeframe: 1 year

Trial details

NCT IDNCT01049711

SponsorMahidol University

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2010-02

View on ClinicalTrials.gov More Chronic Renal Failure trials

Who can participate

Age range

18 Years – 85 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.